Valeant seeing early impact on profits from acquisition of Bausch and Lomb

Home › Valeant seeing early impact on profits from acquisition of Bausch and Lomb

Valeant Pharmaceuticals International Inc. is reporting net income of $124 million for the fourth quarter of 2013, or 36 cents per diluted share.

07.10	Hurricane Milton Public Advisory Number 10A
07.10	Atlantic Tropical Weather Outlook
07.10	Eastern North Pacific Tropical Weather Outlook
07.10	Mark Andy appoints Antony Cotton European sales manager
07.10	Hurricane Milton Potential Storm Surge Flooding Map
07.10	Evonik, BASF Agree on First Delivery of Biomass-Balanced Ammonia
07.10	Hurricane Milton Update Statement
07.10	Summary for Hurricane Milton (AT4/AL142024)
More »

je.st